Should I Be Worried About West Nile Virus in 2026?
For most people, a West Nile bite passes without a symptom, and the 2026 US surge doesn't change that. What it does change is the calculus for a defined group: older adults, and anyone with diabetes, high blood pressure, kidney disease, or a suppressed immune system. There's no vaccine and no antiviral. The medicine right now is repellent on exposed skin, long sleeves outdoors, and dumping standing water weekly.
CDC ArboNET is tracking about 181 US cases across 29 jurisdictions and 11 deaths as of mid-August 2026. That's roughly five times the historical baseline for this point in the year, and the worst early season in 22 years. Arizona alone accounts for more than a third. Maricopa County, the Phoenix metro, has 58 confirmed cases and 5 deaths, and detected virus-positive mosquito pools in February, months earlier than usual. Culex mosquito activity doesn't peak until late August and September, so the worst weeks are still ahead.
Why 80% of early cases looked neuroinvasive
An unsettling figure in early 2026 reports: about 80% of the first 48 confirmed cases were classified as neuroinvasive disease, meaning meningitis, encephalitis, or acute flaccid paralysis. Taken at face value, that would describe a very different virus than the one we've been dealing with. It almost certainly does not. Neuroinvasive cases land in hospitals and get tested. People with a fever, a headache, or nothing at all are invisible to surveillance until the season fills in. Historically fewer than 1% of infections progress to neuroinvasive disease, and the 2026 share should settle closer to that as milder cases catch up.
What a bite most often does
Around 70 to 80% of West Nile infections cause no symptoms. Another 20 to 25% cause a self-limited illness with fever, headache, muscle aches, and sometimes a rash, resolving over days to a couple of weeks. Fewer than 1% progress to the neuroinvasive form. That's where the danger concentrates. Pooled US mortality is about 1 in 10, roughly 4 in 10 need ICU care, and a large share of survivors carry fatigue, memory, and concentration problems for months afterward. Encephalitis has the worst prognosis of the three neuroinvasive syndromes.
Who lands in that small tail
The people who end up in the neuroinvasive tail aren't random. A 2025 JAMA Network Open cohort of 3,064 US patients from 2013 to 2024 and a meta-analysis of 47 US studies converge on the same short list: age, then chronic disease, then anything that suppresses the immune system. Each decade of age raises the risk of neuroinvasive disease by about 10% and mortality by about 32%. In immunosuppressed patients with neuroinvasive disease, 90-day mortality was 28%, versus 7% in immunocompetent patients, a gap that holds across transplant recipients, chemotherapy patients, and people on anti-CD20 biologics.
| Risk factor | How much it raises severe-disease or death risk | Source |
|---|---|---|
| Age 70+ | Case fatality around 21%, versus about 2% for people under 50 | CDC surveillance, 2009-2018 |
| Chronic kidney disease | Roughly six times higher odds of dying | Meta-analysis, Annals of Neurology 2025 |
| Hypertension | About four times higher odds of dying | Meta-analysis, Annals of Neurology 2025 |
| Diabetes | Two to three times higher odds of dying | Meta-analysis, Annals of Neurology 2025 |
| Immunosuppression (transplant, chemo, anti-CD20) | 90-day mortality about 28%, versus 7% otherwise | Cohort study, JAMA Network Open 2024 |
If you're in this group and you develop a sudden fever with headache, confusion, neck stiffness, or new weakness during mosquito season, that warrants the ER, not a wait-and-see.
The medicine that exists right now
There's no licensed West Nile vaccine and no antiviral. Steroids and IVIG have both been tested in neuroinvasive disease; neither improved survival. The one candidate in trials, HydroVax-001B, is a 30-person Phase 1 study that isn't scheduled to complete until November 2027.
That leaves prevention. It's unglamorous and it works. CDC endorses four EPA-registered repellent categories: DEET at 20 to 30%, picaridin at about 20%, IR3535, and oil of lemon eucalyptus or PMD at 30 to 40%. The first three protect the longest. Put them on any exposed skin at dawn and dusk, when Culex bites. Long sleeves and pants outdoors add another layer.
Weekly, dump every container of standing water around the house: the buckets, the plant saucers, the low spot in the yard, the toy that filled with rain. Culex breeds in small volumes of water on the order of days.
For most people this year, a mosquito bite in Phoenix or Dallas or Sacramento will just be a mosquito bite. For older adults, and for anyone with diabetes, high blood pressure, kidney disease, or a suppressed immune system, the same bite in September can mean weeks in an ICU and months of cognitive recovery. What would change that judgment is an approved vaccine or a proven antiviral. Neither exists yet.